April 2008

Findings from a study led by Stephen B. Soumerai, Sc.D., of Harvard Pilgrim Health Care Inc., were highlighted in the The Boston Globe's April 7, 2008 issue of White Coat Notes titled, “Drug Policies Disrupt Care.” In this study, the researchers examined how prior authorization policies for certain medications affected schizophrenic patients. In a parallel, HCFO-funded study, the researchers are evaluating the effects of prior authorization of new medications among Medicaid beneficiaries with bipolar disorder in the state of Maine. 

________________________

In the News Archives